Randomized trial of an education and support intervention to preventreadmission of patients with heart failure
Harlan M. Krumholz, MD, FACC*   ,*,
Joan Amatruda, RN,
Grace L. Smith, MPH,
Jennifer A. Mattera, MPH,
Sarah A. Roumanis, RN,
Martha J. Radford, MD, FACC*,
Paula Crombie, LCSW|| and
Viola Vaccarino, MD, PhD¶
* Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
Yale-New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, Connecticut, USA
Qualidigm®, Middletown, Connecticut, USA
Section of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA
|| Yale-New Haven Hospital, New Haven, Connecticut, USA
¶ Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USAAt the time this work was conducted, Dr. Vaccarino was affiliated with the Section of Chronic Disease Epidemiology, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut
View larger version (11K):
[in a new window]
|
Figure 1 Kaplan-Meier curve for all-cause related readmission or death.
|
|
View larger version (11K):
[in a new window]
|
Figure 2 Kaplan-Meier curve for congestive heart failure (HF)/cardiovascular disease (CVD)-related readmission or death.
|
|
View larger version (11K):
[in a new window]
|
Figure 3 Kaplan-Meier curve for congestive heart failure (HF)-related readmission or death.
|
|
|
